About us

Who we are

Founded in 2021, Cryptobiotix is on a mission to revolutionise preclinical gut microbiome research. The SIFR® technology pipeline is the tool we developed and use, but our company’s success relies on strong partnerships and an excellent team.

Our values

  • Integrity: a partner and data you can trust
  • Innovation: pushing the boundaries of gut and microbiome modelling
  • Collaboration: we succeed when our clients succeed

Meet the team

Aurélien Baudot - CEO of Cryptobiotix

Aurélien Baudot

CEO & co-Founder

Aurélien Baudot holds a double MSc in Bioscience Engineering and Artificial Intelligence. Over the past decade, he has built broad expertise across the biotech sector, specialising in molecular biology, lab automation, advanced analytics, and gut microbiome research. As CEO of Cryptobiotix, he leads the company’s strategic direction and commercial growth, working closely with clients to understand their scientific questions and shape the solutions of tomorrow.
Pieter Van den Abbeele - CSO of Cryptobiotix

Pieter Van den Abbeele

CSO & co-Founder

Dr. Pieter Van den Abbeele is an expert in gut microbiome research and co-inventor of Cryptobiotix’s proprietary SIFR® technology  pipeline. As CSO, he drives the scientific vision and innovation pipeline, ensuring the company’s solutions remain at the forefront of preclinical gastrointestinal simulation. His work bridges the gap between preclinical and clinical research, helping global partners in food, feed, biotech, and pharma to accelerate product development while reducing the reliance on animal testing.

Lien Van den Bossche - Project Manager @ Cryptobiotix

Lien Van den Bossche

Head of Operations

Dr. Lien Van den Bossche oversees all operations at Cryptobiotix, ensuring excellence, quality control, and compliance with regulatory standards. With a background in biotechnology and extensive hands-on experience in microbiome research, she manages the day-to-day execution of projects, the planning of resources, and drives the continuous optimisation of lab workflows. Her leadership ensures that client studies are delivered on time, with the highest scientific and technical standards.

Ingmar van Hengel - Business Development Manager @ Cryptobiotix

Ingmar van Hengel

Director of Business Development

Dr. Ingmar van Hengel leads the global business development efforts at Cryptobiotix, building strategic partnerships and identifying new market opportunities in the food, feed, biotech and pharma sectors. With a scientific and commercial background, he bridges the gap between client needs and the company’s advanced preclinical solutions. Ingmar works closely with R&D and operations teams to design tailored study approaches, helping clients bringing their products faster and more consistently to the market.

Contact form

We’re always happy to hear from potential customers, partners, and collaborators.

Discover

Keep up to date